Compound Conc. (logM) 1 Day 2 Days 7 Days
Apoptosis (mean%, n=2) Necrosis (mean%, n=2) Viable cells (%) Apoptosis (mean%, n=2) Necrosis (mean%, n=2) Viable Cells (%) Apoptosis (mean%, n=2) Necrosis (mean%, n=2) Viable Cells (%)
RFUdR -5 0.7 (1.2)* 0.7 (0.4) 98.6 36.7 (0.1) 9.7 (0.1) 53.6 94.8 (1.0) 0 (0.1) 5.2
-6 0.9 (0.8) 1.7 (3.3) 97.4 12.6 (1.5) 9.7 (1.4) 77.7 62.8 (29.0) 10 (9.7) 27.2
BTCEP-BFUdR -5 0.1 (0.8) 0.2 (1.1) 99.7 21.6 (3.3) 16.3 (1.6) 62.1 84.8 (4.0) 2.5 (3.4) 12.7
-6 0.3 (0.2) 0 (0.2) 99.7 0.3 (0.2) 0.2 (0.7) 99.5 1.5 (1.6) 1.5 (0.4) 97
FUdR -5 0.6 (1.7) 0.5 (0.7) 98.9 27.5 (2.2) 19.8 (0.2) 52.7 83.9 (5.5) 6.9 (8.2) 9.2
-6 0.5 (0.3) 1.8 (0.7) 97.7 19.9 (2.5) 17.8 (1.7) 62.3 38.7 (25.8) 8.9 (2.1) 52.4
RA -5 0.0 (0.2) 0.0 (0.4) 100 0.5 (0.7) 0.0 (0.3) 99.5 56.9 (2.8) 5 (2.5) 38.1
-6 $ $ $ $ $ $ 23.0 (0.4) 4.7 (3.1) 58.9
NaBu -3 0.3 (1.0) 0.0 (0.1) 99.7 0.5 (0.5) 0.0 (0.6) 99.5 1.5 (0.9) 1.2 (1.2) 97.3
*Data have been normalized with reference to the respective control (drug-untreated) data.
#Data in parentheses represents the differences between duplicate experiments.
$No discernible change.
Table 1: Relative contribution (%)* of apoptosis and necrosis to the cell death following exposure of HL-60 cells to RFUdR, BTCEP-BFUdR and reference compounds FUdR, RA and NaBu.
Goto home»